TRAJECTORY OF CARIPRAZINE TREATMENT EFFECTS ACROSS SCHIZOPHRENIA SYMPTOMS: POST HOC ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE-CONTROLLED TRIAL

被引：0
|
作者：
Cutler, Andrew J. [1 ]
Durgam, Suresh [2 ]
Lu, Kaifeng [2 ]
Ruth, Adam [3 ]
Laszlovszky, Istvan [4 ]
Nemeth, Gyoergy [4 ]
Meltzer, Herbert Y. [5 ]
机构：
[1] Florida Clin Res Ctr LLC, Bradenton, IL USA
[2] Forest Res Inst, Jersey City, NJ USA
[3] Prescott Med Commun Grp, Chicago, IL USA
[4] Gedeon Richter Plc, Budapest, Hungary
[5] Northwestern Feinberg Sch Med, Chicago, IL USA
来源：
SCHIZOPHRENIA BULLETIN | 2015年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
2086005
引用
收藏
页码：S308 / S308
页数：1
相关论文
共 50 条
  • [31] A randomized, double-blind, placebo-controlled trial on modafinil for negative symptoms in schizophrenia
    Pierre, Joseph M.
    Peloian, John H.
    Wirshing, Donna A.
    Wirshing, William C.
    Marder, Stephen R.
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (05) : 705 - 710
  • [32] A Randomized, Double-Blind, Placebo- And Active-Controlled, Parallel, Nested Crossover, QT Study of Oteseconazole in Healthy Women
    Degenhardt, T.
    Darpo, B.
    Xue, H.
    Weclaw, C.
    Brand, S.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2024, 231 (06)
  • [33] Efficacy and safety of vilazodone 20 mg and 40 mg in major depressive disorder: A randomized, double-blind, placebo- and active-controlled trial
    Gommoll, C.
    Mathews, M.
    Chen, D.
    Nunez, R.
    Khan, A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 96 - 96
  • [34] Efficacy of Cariprazine in Patients With Bipolar Depression and Mixed Features: Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial
    Stahl, Stephen
    Earley, Willie
    Zhong, Yan
    Patel, Mehul
    Laszlovszky, Istvan
    Nemeth, Gyorgy
    McIntyre, Roger
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S526 - S526
  • [35] Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial
    Durgam, Suresh
    Earley, Willie
    Li, Rui
    Li, Dayong
    Lu, Kaifeng
    Laszlovszky, Istvan
    Fleischhacker, W. Wolfgang
    Nasrallah, Henry A.
    SCHIZOPHRENIA RESEARCH, 2016, 176 (2-3) : 264 - 271
  • [36] Escitalopram in the treatment of negative symptoms in patients with chronic schizophrenia: A randomized double-blind placebo-controlled trial
    Iancu, Iulian
    Tschernihovsky, Eleonora
    Bodner, Ehud
    Piconne, Anna Sapir
    Lowengrub, Katherine
    PSYCHIATRY RESEARCH, 2010, 179 (01) : 19 - 23
  • [37] Escitalopram in the treatment of negative symptoms in chronic schizophrenia patients: A randomized double-blind placebo-controlled trial
    Iancu, I.
    Tchernihovsky, E.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 140 - 140
  • [38] A double-blind placebo controlled trial of modafinil for negative symptoms in schizophrenia
    Pierre, JM
    Peloian, JH
    Wirshing, DA
    Wirshing, WC
    Marder, SR
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S207 - S207
  • [39] A double-blind placebo controlled trial of modafinil for negative symptoms in schizophrenia
    Pierre, J
    Peloian, JH
    Wirshing, DA
    Wirshing, WC
    Marder, SR
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 501 - 501
  • [40] A randomized, double-blind, placebo-controlled trial of ondansetron for the treatment of cocaine use disorder with post hoc pharmacogenetic analysis
    Blevins, Derek
    Seneviratne, Chamindi
    Wang, Xin-Qun
    Johnson, A. Bankole
    Ait-Daoud, Nassima
    DRUG AND ALCOHOL DEPENDENCE, 2021, 228
12345